How to Manage Shoemaker Protocol Documentation for Mould Illness with AI: A 2026 Guide

Chronic Inflammatory Response Syndrome (CIRS) presents a significant clinical challenge, partly because an estimated 25% of the population carries HLA-DR gene variants that confer susceptibility (Dooley et al., PMC, 2024). This genetic predisposition affects at least 52.1 million people in the U.S. alone who may develop CIRS after exposure to a water-damaged building. For these patients, the Shoemaker Protocol offers a structured, evidence-based path to recovery.

The protocol is the only treatment for CIRS with documented clinical efficacy in published literature, as noted in a 2024 systematic review (Dooley et al., Annals of Medicine & Surgery). However, its 12-step sequential framework, which tracks over eight core serum biomarkers, generates a substantial documentation burden. Managing this complex, multi-phase process requires meticulous record-keeping over many months. This guide outlines how clinicians can use AI to streamline Shoemaker protocol CIRS AI documentation, reducing administrative tasks while maintaining high standards of care.

Key Takeaways

• Approximately 25% of the population carries HLA-DR variants linked to biotoxin susceptibility (PMC, 2024).
• The Shoemaker Protocol tracks 8+ serum biomarkers across 12 sequential treatment steps.
• AI documentation tools can reduce clinician burnout by over 13 percentage points (PMC/JAMA, 2025).
• CIRS documentation is among the most complex in functional medicine, making it ideal for AI assistance.

Why Is CIRS Documentation So Complex?

The Shoemaker Protocol is a 12-step sequential treatment framework that tracks at least eight core serum biomarkers over 30 years and 14,000 patients (SurvivingMold.com). This complexity stems from the protocol’s multi-system approach, requiring clinicians to document changes across the biotoxin pathway, not just isolated symptoms. Each step builds on the last, demanding precise and context-aware notes.

The core biomarker panel alone is extensive. We must track C4a, TGF-beta1, MMP-9, MSH, VEGF, and VIP. We also monitor hormone axes with ACTH/Cortisol and ADH/Osmolality. This data is layered with foundational markers like HLA-DR genetic susceptibility, Visual Contrast Sensitivity (VCS) test results, and nasal swabs for MARCoNS. Environmental data, such as an ERMI score from the patient's home, adds another critical layer.

Each of the 12 steps requires documenting lab values, treatment adjustments, and the patient's subjective response. For example, moving from Step 4 (removing biotoxins with cholestyramine) to Step 5 (eradicating MARCoNS) depends entirely on the documented resolution of specific symptoms and lab markers. Without meticulous, phase-aware documentation, it's nearly impossible to navigate the protocol effectively.

The need for this rigorous approach is underscored by the prevalence of exposure sources. An estimated 85% of U.S. buildings have experienced past water damage, with 45% having current leak issues (EPA BASE Study). This isn't a rare condition triggered by an obscure exposure. It's a common clinical reality demanding a sophisticated documentation strategy. How can we manage this without getting buried in administrative work?

Step 1: Build a CIRS-Specific Assessment Template

A successful CIRS case begins with a detailed initial assessment, and the Visual Contrast Sensitivity (VCS) test provides a crucial starting point with 92% accuracy for screening (SurvivingMold.com). When combined with specific symptom clusters, its diagnostic accuracy climbs to 98.5%. A generic functional medicine intake form simply won't capture the necessary detail for a CIRS workup.

Your initial assessment template must be purpose-built for mould illness. Standard EHR templates often lack fields for the specific data points required by the Shoemaker Protocol. This forces clinicians into free-texting complex information, which hinders data tracking and creates inconsistencies. A structured, CIRS-specific template ensures you gather the right information from the very first visit.

The template should be organized into four key sections. First, a detailed environmental exposure history, including questions about water-damaged buildings at home, work, and school. Second, a symptom cluster scoring section based on Dr. Shoemaker's published criteria. Third, a section to record initial screening results like the VCS test and orders for initial labs, including HLA-DR. Finally, a structured area for your clinical impression and initial plan.

Using an AI-assisted tool, you can build this template once and deploy it for every new CIRS patient. The AI can then use the structured data from this initial assessment to inform all subsequent documentation, from lab reviews to follow-up notes. This creates a coherent patient story grounded in the specific requirements of the biotoxin pathway. This is the foundation for effective patient outcome tracking.

Step 2: Configure Protocol-Aware Lab Review Templates

Physicians spend an average of 13 hours per week on indirect patient care, much of it within the EHR (AMA, 2024). Reviewing complex CIRS labs is a significant contributor to this administrative burden. An AI-powered, protocol-aware lab review template can parse these results efficiently, interpreting them through the specific lens of the Shoemaker Protocol.

The core of CIRS management involves tracking the eight key biomarkers across the 12 treatment steps. A lab review note should do more than just list values. It needs to interpret them within the context of the patient's current protocol phase. For instance, an elevated C4a has different clinical implications at Step 3 versus Step 8. Your documentation must reflect this nuance.

A critical failure of standard EHRs is their reliance on conventional lab ranges. CIRS markers like TGF-beta1 and MMP-9 require interpretation based on functional ranges established in Dr. Shoemaker's research. Your template must be configured to flag values based on these specific thresholds, not the lab's default reference range.

This is where phase-aware documentation becomes essential. An AI assistant can be configured to understand the 12 steps of the protocol. When you review a new set of labs, the AI can automatically compare the results to the previous set, note the patient's current treatment phase, and draft an interpretation based on expected changes for that specific step. This supports, but never replaces, your clinical judgment.

Step 3: Automate Phase-Specific Care Plans

With physician AI usage jumping from 38% to 66% in just one year (AMA, 2025), clinicians are increasingly using these tools to streamline care plan creation. For a protocol as structured as Shoemaker's, AI can map the 12 steps to distinct care plan phases, automating the generation of treatment instructions and patient education materials.

The Shoemaker Protocol is inherently sequential. You cannot effectively treat MARCoNS (Step 7) if the patient still has a significant biotoxin load that should be addressed with cholestyramine (Step 4). Your AI-generated care plans must reflect this logic. By defining each of the 12 steps as a "phase," the AI can generate a care plan that corresponds directly to the patient's current position in the protocol.

For example, when a patient is in Step 4, the AI can draft a care plan that includes instructions for CSM titration, reminders about timing with other medications, and information on potential side effects. Once labs and symptoms indicate readiness to advance, you can trigger the AI to generate the care plan for Step 5, which might include details on BEG spray for MARCoNS.

This phase-aware documentation ensures consistency and accuracy. The AI knows which step the patient is on based on previous notes and lab data. This allows it to generate relevant medication and supplement lists, educational resources, and follow-up instructions automatically. You, the clinician, simply review, edit, and approve, saving significant time while ensuring the patient receives clear, step-appropriate guidance.

Step 4: Generate Follow-Up Notes with Protocol Context

The adoption of ambient AI scribes has been shown to reduce physician burnout from 51.9% to 38.8% across hundreds of practitioners (PMC/JAMA, 2025). This is largely due to the technology's ability to handle the most time-consuming part of the visit: documentation. For CIRS follow-ups, an AI scribe that understands the protocol's context is invaluable.

A standard SOAP note is insufficient for a CIRS follow-up. The note must reference previous biomarker values and explicitly state whether the patient has met the criteria to advance to the next protocol step. An AI assistant trained on the Shoemaker Protocol can listen to the patient encounter and draft a note that includes this critical context automatically.

Imagine a follow-up visit for a patient on Step 4 (CSM). The AI can draft a note that pulls in their previous C4a and TGF-beta1 levels, compares them to the current labs you're discussing, and notes the percentage of improvement. It can also document the resolution of specific symptom clusters, such as a reduction in fatigue or cognitive fog, which are prerequisites for moving forward.

This creates a clear, longitudinal record of the patient's journey through the protocol. Each note builds on the last, providing a rationale for every clinical decision. Are they ready to stop CSM? Have they passed a repeat VCS test? Has their MMP-9 normalized? A protocol-aware AI helps ensure these key decision points are documented accurately and efficiently, freeing you to focus on the patient. This is a core part of how to automate patient documentation.

Step 5: Track Biomarker Trends Across the Protocol Timeline

The global mycotoxin testing market is projected to grow from $1.5 billion to $2.3 billion by 2029 (MarketsandMarkets, 2024), reflecting a growing recognition of biotoxin illness. As clinicians, we need tools that can help us track the impact of these biotoxins on our patients' physiology over time. AI offers a powerful way to visualize and analyze these longitudinal biomarker trends.

Effective CIRS management requires more than just looking at a single lab report. You need to see the trajectory of C4a, TGF-beta1, and MMP-9 over several months. An AI-powered dashboard can plot these values on a timeline, mapping them against treatment changes. This visual representation makes it much easier to assess the patient's response to interventions like cholestyramine or VIP spray.

Furthermore, the AI can be programmed with the protocol's logic for re-testing. It can prompt you when it's time to re-check MMP-9 after starting CSM or when to assess C4a after a change in exposure. This helps ensure you're gathering the right data at the right time without having to manually track re-testing schedules for every patient.

Over time, this system can help identify patterns across your entire CIRS patient population. Are patients with a specific HLA-DR haplotype responding slower to CSM? Does a particular ERMI score correlate with higher initial C4a levels? By structuring the data from the start, AI can help uncover clinical insights that would be nearly impossible to find by manually reviewing individual charts.

Common Mistakes in CIRS Documentation

Navigating the Shoemaker Protocol is complex, and documentation errors can lead to clinical missteps. Even experienced practitioners can make mistakes without a systematic approach. With 43.2% of U.S. physicians reporting burnout in 2024 (AMA), streamlining this process is critical. Here are four common pitfalls to avoid.

First is failing to document the exposure history thoroughly. Simply noting "mould exposure" is not enough. You need to document the timing, location (home, work), and remediation status, including data like ERMI scores when available. This information is crucial for Step 1 of the protocol.

Second is using standard lab ranges instead of CIRS-specific functional ranges. A TGF-beta1 level that is "normal" by a conventional lab's standards may be significantly elevated for a CIRS patient. Your notes must reflect interpretation based on the correct, protocol-defined ranges.

Third, and perhaps most critical, is not using phase-aware documentation. A clinical note that doesn't specify which of the 12 steps the patient is currently on lacks essential context. This makes it difficult for you or another clinician to understand the treatment rationale and track progress over time.

Finally, a common error is treating biomarkers in isolation. The Shoemaker Protocol relies on interpreting a panel of markers together. A note that focuses only on a rising C4a without considering the corresponding MMP-9 or TGF-beta1 tells an incomplete story. Your documentation should reflect this integrated, systems-based analysis.

Frequently Asked Questions

How many biomarkers does the Shoemaker Protocol track?

The core protocol tracks at least eight key serum biomarkers to assess the biotoxin pathway, including C4a, TGF-beta1, and MMP-9. Developed over 30 years with over 14,000 patients, it also incorporates other data points like HLA-DR genetics, MARCoNS status, and VCS test results (SurvivingMold.com).

Can AI interpret CIRS lab results without practitioner oversight?

No. AI tools are designed to support, not replace, clinical judgment. An AI assistant can flag abnormal values based on CIRS-specific ranges, compare them to previous results, and draft a summary. However, the final interpretation and clinical decision-making must always be performed by a qualified practitioner.

How long does a typical Shoemaker Protocol treatment take?

The duration varies significantly based on the patient's toxic load, genetic susceptibility, and adherence to the protocol. Treatment can take anywhere from six months to several years. The protocol's 12 sequential steps must be completed in order, and a patient only advances after meeting specific clinical and laboratory criteria.

What makes CIRS documentation different from other functional medicine cases?

CIRS documentation is uniquely complex due to the Shoemaker Protocol's sequential, multi-phase nature. Unlike a GI-MAP interpretation, CIRS notes must be "phase-aware," explicitly referencing which of the 12 steps the patient is on and tracking a large, specific panel of biomarkers over a long period.

Which EHRs support CIRS-specific documentation workflows?

Most standard EHRs do not have built-in templates for the Shoemaker Protocol. Clinicians often use flexible platforms like Cerbo or Practice Better and build their own templates. AI assistants designed for functional medicine can integrate with these EHRs to provide a layer of protocol-specific intelligence on top.

Explore CIRS Protocol Documentation with Meelio

Managing the documentation for the Shoemaker Protocol requires a level of precision and consistency that can be challenging to maintain manually. An AI assistant built for the complexities of functional medicine can provide the structure and efficiency needed to treat CIRS patients effectively without succumbing to administrative burnout. By implementing protocol-aware templates and phase-specific automation, you can focus your expertise where it matters most: on your patient.

If you’re ready to see how an AI clinical assistant can streamline your CIRS documentation workflow, explore Meelio.

Start a free trial of Meelio